A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Namenda Indications, Dosage, Storage, Stability - Memantine
Namenda Indications, Dosage, Storage, Stability - Memantine
INDICATIONS AND USAGE
NAMENDA (memantine hydrochloride) is indicated for the treatment
of moderate to severe dementia of the Alzheimer’s type.
DOSAGE AND ADMINISTRATION
The dosage of NAMENDA (memantine hydrochloride) shown
to be effective in controlled clinical trials is 20 mg/day.
The recommended starting dose of NAMENDA is 5 mg once daily.
The recommended target dose is 20 mg/day. The dose should be increased in 5
mg increments to 10 mg/day (5 mg twice a day), 15 mg/day (5 mg and 10 mg as
separate doses), and 20 mg/day (10 mg twice a day). The minimum recommended
interval between dose increases is one week.
NAMENDA can be taken with or without food.
Doses in Special Populations
Dose reduction in patients with moderate renal impairment should
be considered. In patients with severe renal impairment the use of NAMENDA has
not been systematically evaluated and is not recommended. (See Clinical
Pharmacology-Pharmacokinetics)
HOW SUPPLIED
5 mg Tablet:
Bottle of 60 NDC #0456-3205-60
10 x 10 Unit Dose NDC #0456-3205-63
The capsule shaped film-coated tablets are tan, with the strength
(5) debossed on one side and FL on the other.
10 mg Tablet:
Bottle of 60 NDC #0456-3210-60
10 x 10 Unit Dose NDC #0456-3210-63
The capsule shaped film-coated tablets are gray, with the strength
(10) debossed on one side and FL on the other.
Titration Pak:
PVC/Aluminum Blister package containing 49 tablets. 28 x 5
mg and 21 x 10 mg tablets. NDC #0456-3200-14
The 5 mg capsule shaped film-coated tablets are tan, with the
strength (5) debossed on one side and FL on the other.
The 10 mg capsule shaped film-coated tablets are gray, with
the strength (10) debossed on one side and FL on the other.
Store at 25° C (77°
F); excursions permitted to 15-30° C
(59-86° F)[see USP Controlled Room Temperature]
Forest Pharmaceuticals, Inc. Subsidiary of
Forest Laboratories, Inc. St. Louis, MO 63045 Licensed from Merz Pharmaceuticals
GmbH, 10/03 © 2003 Forest Laboratories, Inc.
Revised Nov 05, 2003
top
